[{"id":"ef5f595b-9e34-4513-9b8d-50b1aa6a34da","acronym":"","url":"https://clinicaltrials.gov/study/NCT03176381","created_at":"2021-01-18T15:39:48.196Z","updated_at":"2024-07-02T16:35:29.387Z","phase":"","brief_title":"Tissue Predictors of Abiraterone Benefit","source_id_and_acronym":"NCT03176381","lead_sponsor":"Tianjin Medical University Second Hospital","biomarkers":" YAP1 • PCNA","pipe":" | ","alterations":" YAP1 positive • PCNA expression","tags":["YAP1 • PCNA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e YAP1 positive • PCNA expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e abiraterone acetate"],"overall_status":"Completed","enrollment":" Enrollment 110","initiation":"Initiation: 05/05/2017","start_date":" 05/05/2017","primary_txt":" Primary completion: 05/01/2023","primary_completion_date":" 05/01/2023","study_txt":" Completion: 11/01/2023","study_completion_date":" 11/01/2023","last_update_posted":"2023-11-14"}]